The development of suitable drug delivery carriers is significant in biomedical applications to
improve the therapeutic efficiency. Recent progress in nanotechnological fields, paved the …

Central nervous system disorders, especially neurodegenerative diseases, are a public
health priority and demand a strong scientific response. Various therapy procedures have …

Peptides comprise a versatile class of biomolecules that present a unique chemical space
with diverse physicochemical and structural properties. Some classes of peptides are able to …

The blood–brain barrier is a major obstacle in treating brain-related disorders, as it does not
allow the delivery of drugs into the brain. We developed a method for predicting blood–brain …

Misfolding and aggregation of amyloid-β (Aβ) peptides are key hallmarks of Alzheimer's
disease (AD). With accumulating evidence suggesting that different Aβ species have varied …

Brain tumors are the leading cause of cancer-related death in children, and
medulloblastoma (MB) is the most common malignant pediatric brain tumor. Advances in …

Glioblastoma is the most common and aggressive brain tumor. Current treatments do not
allow to cure the patients. This is partly due to the blood–brain barrier (BBB), which limits the …

Piezoelectric materials can evoke electrochemical reactions by transferring charge carriers
to reactants upon receiving mechanical stimuli. We report a newly discovered function of …

Central nervous system (CNS) disorders represent a broad spectrum of brain ailments with
short-and long-term disabilities, and nanomedicine-based approaches provide a new …

The advancement of tissue and cell-specific drug delivery systems is a key to precision
cancer therapy. Peptides, with easy synthesis, low immunogenicity and biological functions …